文献速递重症综合管理与镇静镇痛

重症药师改善患者救治的作用:基于药物方案复杂性-ICU(MRC-ICU)评分的大型多中心有意义的指标分析

Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen Complexity-ICU (MRC-ICU) Score.
PubMed 文献 · Crit Care Med · 2022-08-15
一句话结论多中心观察性队列显示,MRC-ICU评分越高,病死率、ICU住院时间、药师干预数量与强度越高;患者:药师比越高,ICU住院时间越长、干预数量与强度越低。

该研究为美国28个ICU的多中心观察性队列,纳入3,908例成人ICU患者,前瞻性记录4周内重症药师干预的数量与类型,回顾性记录MRC-ICU评分与患者结局。方差分析显示MRC-ICU与病死率(OR 1.09;95%CI 1.08-1.11;p<0.01)、ICU住院时间(β 0.41;95%CI 0.37-0.45;p<0.01)、药师干预总数(β 0.07;95%CI 0.04-0.09;p<0.01)及干预强度复合评分(β 0.19;95%CI 0.11-0.28;p<0.01)显著相关。多因素回归中,患者:药师比升高与ICU住院时间延长(β 0.02;95%CI 0.00-0.04;p=0.02)、干预数量减少(β -0.03;95%CI -0.04至-0.02;p<0.01)及干预强度降低(β -0.05;95%CI -0.09至-0.01)相关。作者认为这些结果提示药师工作量增加与照护减少及患者结局恶化相关,值得进一步探索人员配置模型与患者结局。

要点

  • MRC-ICU评分越高,病死率越高(OR 1.09;95%CI 1.08-1.11;p<0.01),ICU住院时间越长(β 0.41;95%CI 0.37-0.45;p<0.01)。
  • MRC-ICU评分越高,药师干预总数(β 0.07;95%CI 0.04-0.09;p<0.01)及干预强度复合评分(β 0.19;95%CI 0.11-0.28;p<0.01)越高。
  • 患者:药师比升高与ICU住院时间延长相关(β 0.02;95%CI 0.00-0.04;p=0.02)。
  • 患者:药师比升高与药师干预数量减少(β -0.03;95%CI -0.04至-0.02;p<0.01)及干预强度降低(β -0.05;95%CI -0.09至-0.01)相关。
  • 作者认为药师工作量增加与照护减少及患者结局恶化相关,值得进一步探索人员配置模型与患者结局。

适用人群与场景

  • 美国28个ICU的成人ICU患者,共3,908例。

研究设计与关键结果

  • 研究设计:多中心观察性队列研究,美国28个ICU,纳入3,908例成人ICU患者。
  • 干预:前瞻性记录4周内重症药师对重症患者药物方案的干预(数量与类型);回顾性记录MRC-ICU评分与患者结局(病死率和住院时间)。
  • 方差分析:MRC-ICU与病死率显著相关(OR 1.09;95%CI 1.08-1.11;p<0.01)。
  • 方差分析:MRC-ICU与ICU住院时间显著相关(β系数 0.41;95%CI 0.37-0.45;p<0.01)。
  • 方差分析:MRC-ICU与药师干预总数显著相关(β系数 0.07;95%CI 0.04-0.09;p<0.01)。
  • 方差分析:MRC-ICU与药师干预强度复合评分显著相关(β系数 0.19;95%CI 0.11-0.28;p<0.01)。
  • 多因素回归:患者:药师比升高与ICU住院时间延长显著相关(β系数 0.02;95%CI 0.00-0.04;p=0.02)。
  • 多因素回归:患者:药师比升高与干预数量减少(β系数 -0.03;95%CI -0.04至-0.02;p<0.01)及干预强度降低(β系数 -0.05;95%CI -0.09至-0.01)显著相关。

证据类型、等级与局限

  • 证据类型:多中心观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,增加药物方案复杂性(以MRC-ICU定义)与病死率、住院时间、干预数量及干预强度增加相关。
  • 作者认为,这些结果提示药师工作量增加与照护减少及患者结局恶化相关,值得进一步探索人员配置模型与患者结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Despite the established role of the critical care pharmacist on the ICU multiprofessional team, critical care pharmacist workloads are likely not optimized in the ICU. Medication regimen complexity (as measured by the Medication Regimen Complexity-ICU [MRC-ICU] scoring tool) has been proposed as a potential metric to optimize critical care pharmacist workload but has lacked robust external validation. The purpose of this study was to test the hypothesis that MRC-ICU is related to both patient outcomes and pharmacist interventions in a diverse ICU population.

DESIGN: This was a multicenter, observational cohort study.

SETTING: Twenty-eight ICUs in the United States.

PATIENTS: Adult ICU patients.

INTERVENTIONS: Critical care pharmacist interventions (quantity and type) on the medication regimens of critically ill patients over a 4-week period were prospectively captured. MRC-ICU and patient outcomes (i.e., mortality and length of stay [LOS]) were recorded retrospectively.

MEASUREMENTS AND MAIN RESULTS: A total of 3,908 patients at 28 centers were included. Following analysis of variance, MRC-ICU was significantly associated with mortality (odds ratio, 1.09; 95% CI, 1.08-1.11; p < 0.01), ICU LOS (β coefficient, 0.41; 95% CI, 00.37-0.45; p < 0.01), total pharmacist interventions (β coefficient, 0.07; 95% CI, 0.04-0.09; p < 0.01), and a composite intensity score of pharmacist interventions (β coefficient, 0.19; 95% CI, 0.11-0.28; p < 0.01). In multivariable regression analysis, increased patient: pharmacist ratio (indicating more patients per clinician) was significantly associated with increased ICU LOS (β coefficient, 0.02; 0.00-0.04; p = 0.02) and reduced quantity (β coefficient, -0.03; 95% CI, -0.04 to -0.02; p < 0.01) and intensity of interventions (β coefficient, -0.05; 95% CI, -0.09 to -0.01).

CONCLUSIONS: Increased medication regimen complexity, defined by the MRC-ICU, is associated with increased mortality, LOS, intervention quantity, and intervention intensity. Further, these results suggest that increased pharmacist workload is associated with decreased care provided and worsened patient outcomes, which warrants further exploration into staffing models and patient outcomes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Sikora A, Ayyala D, Rech MA, et al. Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen Complexity-ICU (MRC-ICU) Score. Crit Care Med. 2022. PMID: 35678204. doi:10.1097/CCM.0000000000005585

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。